[C-peptide and the importance of its determination]

[Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].

Vnitrni lekarstvi·2013

[Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBYII study (observations lasting 24 months)].

Vnitrni lekarstvi·2013

[Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus].

Vnitrni lekarstvi·2008

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).

Diabetes, obesity & metabolism·2008

[Incretin strategy in the treatment of type 2 diabetes mellitus--the DPP-IV inhibitor sitagliptin].

Vnitrni lekarstvi·2007

[Incretin strategy in the treatment of type 2 diabetes mellitus--DPPIV].

Vnitrni lekarstvi·2007

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023

A GC-globulin-based supramolecular sensor array for discrimination of androgens and estrogens in urine.

Chemical communications (Cambridge, England)·2026

A H2S-activatable NIR-II aza-BODIPY probe for early detection of drug-induced liver injury.

Chemical communications (Cambridge, England)·2026

Design and Development of Aptamer-Gold Nanoparticle Based Colorimetric Assays for In-the-field Applications.

Journal of visualized experiments : JoVE·2026

A Surgical Algorithm for Upper Cervical Trauma Based on the AO Spine Upper Cervical Injury Classification System.

Spine·2026

Methods for analyzing acetylcholine-induced vasodilation in human skin.

Journal of applied physiology (Bethesda, Md. : 1985)·2026

Safety Comparison of Acetylcholinesterase Inhibitors Using FAERS Spontaneous-Reporting Data: Drug-Specific Reporting Signals and Time-to-Onset Dynamics.

Current Alzheimer research·2026

Related Experiment Videos

[C-peptide and the importance of its determination]

Related Concept Videos

[Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].

[Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBYII study (observations lasting 24 months)].

[Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus].

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).

[Incretin strategy in the treatment of type 2 diabetes mellitus--the DPP-IV inhibitor sitagliptin].

[Incretin strategy in the treatment of type 2 diabetes mellitus--DPPIV].

Pharmacological profile of mepolizumab.

Atypical form of Goodpasture's disease.

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Dyslipidemia - the known unknown.

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Implications of highly suppressive treatment HIV infection.

A GC-globulin-based supramolecular sensor array for discrimination of androgens and estrogens in urine.

A H2S-activatable NIR-II aza-BODIPY probe for early detection of drug-induced liver injury.

Design and Development of Aptamer-Gold Nanoparticle Based Colorimetric Assays for In-the-field Applications.

A Surgical Algorithm for Upper Cervical Trauma Based on the AO Spine Upper Cervical Injury Classification System.

Methods for analyzing acetylcholine-induced vasodilation in human skin.

Safety Comparison of Acetylcholinesterase Inhibitors Using FAERS Spontaneous-Reporting Data: Drug-Specific Reporting Signals and Time-to-Onset Dynamics.

Related Experiment Videos

[C-peptide and the importance of its determination]

Related Concept Videos

Related Articles